AEGiS-APPJ: AIDS and Intravenous Drug Use in San Francisco AIDS & Public Policy JournalImportant note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu
DonateNow
Print this Article


AIDS and Intravenous Drug Use in San Francisco

AIDS & Public Policy Journal 3, no. 2 (1988): 37-41
Andrew R. Moss and Richard E. Chaisson


In the AIDS Epidemiology Group at San Francisco General Hospital (SFGH), we began to study HIV infection among IVDUs, primarily those in treatment, in 1984. In 1985 we began a testing-and-diversion program, described below, aimed at intervening in the spread of HIV among drug users. On the basis of several years of testing IVDUs and retrospective testing of stored sera (from which the 1983-84 data are derived), we now have a relatively clear picture of the spread of HIV among drug users in San Francisco. Since at least one seropositive IVDU was known in San Francisco in 1978, the data suggest a relatively slow but steady increase in the seropositivity rate in the IVDU treatment program population over the past decade, up to the current rate of 13 percent.
880315
APPJ883206

Copyright © 1988 - AIDS & Public PolicyJournal. Reproduction of this article (other than one copy for personal reference) must be cleared through the APPJ Permissions Desk.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, Bridgestone/Firestone Charitable Trust, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1986, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .